HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.

Abstract
Inflammatory bowel disease is characterised by oxidative and nitrosative stress, leukocyte infiltration, upregulation of the expression of intercellular adhesion molecule 1 (ICAM-1) and upregulation of P-selectin in the colon. Here, we investigate the effects of the selective cyclo-oxygenase-2 inhibitor, celecoxib, in rats subjected to experimental colitis. Colitis was induced in rats by intracolonic instillation of dinitrobenzene sulfonic acid (DNBS). Rats experienced hemorrhagic diarrhoea and weight loss. At 4 days after administration of DNBS, the mucosa of the colon exhibited large areas of necrosis. Neutrophil infiltration (determined by histology, as well as an increase in myeloperoxidase activity in the mucosa) was associated with upregulation of ICAM-1 and P-selectin, as well as high tissue levels of malondialdehyde. Immunohistochemistry for nitrotyrosine and poly(ADP-ribose) polymerase showed intense staining in the inflamed colon. Celecoxib (5 mg/kg twice a day orally) significantly reduced the degree of hemorrhagic diarrhoea and the weight loss caused by administration of DNBS. Celecoxib also caused a substantial reduction of (i) the degree of colonic injury, (ii) the rise in myeloperoxidase activity (mucosa), (iii) the increase in the tissue levels of malondialdehyde, (iv) the increase in staining (immunohistochemistry) for nitrotyrosine, as well as (v) the upregulation of ICAM-1 and P-selectin caused by DNBS in the colon. Thus, we provide the first evidence that a selective cyclo-oxygenase-2 inhibitor celecoxib reduces the degree of colitis caused by DNBS.
AuthorsS Cuzzocrea, E Mazzon, I Serraino, L Dugo, T Centorrino, A Ciccolo, L Sautebin, A P Caputi
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 431 Issue 1 Pg. 91-102 (Nov 09 2001) ISSN: 0014-2999 [Print] Netherlands
PMID11716847 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzenesulfonates
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Cytokines
  • Isoenzymes
  • P-Selectin
  • Pyrazoles
  • Sulfonamides
  • dinitrobenzenesulfonic acid
  • Intercellular Adhesion Molecule-1
  • Peroxynitrous Acid
  • Peroxidase
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • Poly(ADP-ribose) Polymerases
  • Celecoxib
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Benzenesulfonates
  • Body Weight
  • Celecoxib
  • Colitis (chemically induced, drug therapy, immunology, physiopathology)
  • Colon (drug effects, metabolism, pathology)
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors (therapeutic use)
  • Cytokines (immunology)
  • Immunohistochemistry
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Isoenzymes (analysis)
  • Lipid Peroxidation
  • Male
  • Neutrophils (immunology)
  • P-Selectin (metabolism)
  • Peroxidase (metabolism)
  • Peroxynitrous Acid (analysis)
  • Poly(ADP-ribose) Polymerases (analysis)
  • Prostaglandin-Endoperoxide Synthases (analysis)
  • Pyrazoles
  • Rats
  • Rats, Sprague-Dawley
  • Sulfonamides (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: